|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Fixed maturity securities (amortized cost $5,802,102; $5,449,726) | ||||||||||||||||||||
| Equity securities (cost $860,929; $728,460) | ||||||||||||||||||||
| Short-term investments (cost $368,338; $336,978) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Premiums | ||||||||||||||||||||
| Allowance for credit losses on premiums receivable | ||||||||||||||||||||
| Premiums receivable, net of allowance for credit losses | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total receivables | ||||||||||||||||||||
| Allowance for credit losses on reinsurance recoverables | ||||||||||||||||||||
| Reinsurance recoverables (net of allowance for credit losses $1; $39) | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Fixed assets (net of accumulated depreciation $376,010; $345,930) | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Current income taxes | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Loss and loss adjustment expense reserves | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Current income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock without par value or stated value: Authorized 70,000 shares; issued and outstanding 55,389; 55,389 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
